Medical device regulators at the US Food and Drug Administration have clarified guidance on how manufacturers should utilize the ISO 10993 standard for biological evaluations of medical devices.
The updated guidance replaces guidance the agency had finalized in 2016 that emphasized biological evaluations in conjunction with risk management considerations for sterile and non-sterile medical device premarket applications, including 510(k) premarket notifications, Premarket Approvals (PMA) and De Novo requests for designation. The guidance specifically addresses ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.”
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
"device" - Google News
September 15, 2020 at 09:54PM
https://ift.tt/2Fwdrqi
FDA updates final guidance on ISO 10993 for medical device biocompatibility - Mass Device
"device" - Google News
https://ift.tt/2KSbrrl
https://ift.tt/2YsSbsy
Bagikan Berita Ini
I think this is one of the most significant info for me.
ReplyDeleteBiocompatibility Testing Services
Biocompatibility For Medical Devices
Thank you so much to share such useful information and makes me more knowledgeable.
ReplyDeleteBiocompatibility Services For Medical Devices
Biocompatibility For Medical Devices
Thank you so much to share such useful information and makes me more knowledgeable.
ReplyDeletebiocompatibility testing for medical devices
Biocomp Testing
Thank you so much to share such useful information and makes me more knowledgeable.
ReplyDeleteBiocompatibility For Medical Devices
Biocompatibility Testing